TY - JOUR
T1 - The GenderCOS project
T2 - study protocol for the development of two international Core Outcome Sets for genital gender affirming surgery
AU - Roijer, Philippine J.
AU - Vallinga, Marleen S.
AU - Pidgeon, Thomas E.
AU - Ceulemans, Aline
AU - Bakker, Alex
AU - Carrière, Brenda
AU - Rashid, Tina
AU - Bellringer, James
AU - Belinky, Javier
AU - Buncamper, Marlon
AU - Morrison, Shane D.
AU - Bouman, Walter P.
AU - Bouman, Mark Bram
AU - Mullender, Margriet G.
N1 - Publisher Copyright: © 2023 Taylor & Francis Group, LLC.
PY - 2023
Y1 - 2023
N2 - Background: Worldwide an increasing number of transgender and gender diverse individuals are requesting genital Gender Affirming Surgery (gGAS). For both masculinizing and feminizing gGAS various procedures and techniques are employed. Current literature on gGAS reports heterogeneous, non-standardized and often ill-defined outcomes. Presently, no consensus exists on what outcomes should be evaluated in order to assess the clinical results and the effectiveness of these procedures, which precludes development of evidence-based treatment guidelines. Aims: This international consensus study aims to develop Core Outcome Sets (COS) for both masculinizing and feminizing gGAS. These represent the minimum sets of outcomes recommended to be measured and reported in all clinical trials pertaining to gGAS. Methods: Two Core Outcome Sets for masculinizing and feminizing gGAS will be developed in parallel by following the Core Outcome Measures in Effectiveness Trials (COMET) guidelines. The stages of development for each set are: i) Identify outcomes measured and reported in previous research through a systematic review of the literature; ii) Identify outcomes suggested by transgender and gender diverse individuals during focus groups and interviews; iii) Combine and structure the outcomes into a preliminary outcome list; iv) Conduct e-Delphi surveys among stakeholders (i.e. professionals in transgender healthcare and transgender individuals) in which all potential outcomes will be rated on level of importance; and v) Decide on the final COS during an online consensus meeting. Discussion: This study will produce minimum, core sets of relevant outcomes for gGAS, through reaching international consensus with key stakeholders, including transgender individuals. Development of these COS will enable the measurement and reporting of relevant and standardized outcomes, facilitating continued scientific advancement of this field.
AB - Background: Worldwide an increasing number of transgender and gender diverse individuals are requesting genital Gender Affirming Surgery (gGAS). For both masculinizing and feminizing gGAS various procedures and techniques are employed. Current literature on gGAS reports heterogeneous, non-standardized and often ill-defined outcomes. Presently, no consensus exists on what outcomes should be evaluated in order to assess the clinical results and the effectiveness of these procedures, which precludes development of evidence-based treatment guidelines. Aims: This international consensus study aims to develop Core Outcome Sets (COS) for both masculinizing and feminizing gGAS. These represent the minimum sets of outcomes recommended to be measured and reported in all clinical trials pertaining to gGAS. Methods: Two Core Outcome Sets for masculinizing and feminizing gGAS will be developed in parallel by following the Core Outcome Measures in Effectiveness Trials (COMET) guidelines. The stages of development for each set are: i) Identify outcomes measured and reported in previous research through a systematic review of the literature; ii) Identify outcomes suggested by transgender and gender diverse individuals during focus groups and interviews; iii) Combine and structure the outcomes into a preliminary outcome list; iv) Conduct e-Delphi surveys among stakeholders (i.e. professionals in transgender healthcare and transgender individuals) in which all potential outcomes will be rated on level of importance; and v) Decide on the final COS during an online consensus meeting. Discussion: This study will produce minimum, core sets of relevant outcomes for gGAS, through reaching international consensus with key stakeholders, including transgender individuals. Development of these COS will enable the measurement and reporting of relevant and standardized outcomes, facilitating continued scientific advancement of this field.
KW - Delphi
KW - core outcome set
KW - gender affirming treatment
KW - gender diverse
KW - genital gender affirming surgery
KW - location VUmc (no. 2022.0102)
KW - the project is prospectively registered in the Core Outcome Measures in Effectiveness Trials (COMET) database (nos. 2064 and 2067). The protocol was approved by the Ethical Review Board of the Amsterdam UMC
KW - transgender
UR - http://www.scopus.com/inward/record.url?scp=85179739205&partnerID=8YFLogxK
U2 - 10.1080/26895269.2023.2288881
DO - 10.1080/26895269.2023.2288881
M3 - Article
SN - 2689-5269
JO - International Journal of Transgender Health
JF - International Journal of Transgender Health
ER -